Monoclonal antibodies bind to
specific undesirable molecules or cells, often destroying them in the process.
They can be used like antibiotics or antivirals, as a way to kill viruses or
bacteria; they can also be used to detect the presence of infectious agents or
to clear bacterial toxins from the bloodstream. And, like vaccines, they can
confer immunity against biological agents. For example, an antibody combination
that attaches to anthrax toxin and clears it from the body is under study. The
technology could be applied to other biowarfare threats, such as dengue fever,
Ebola and Marburg viruses, and plague.
Adjuvants/Immunostimulants
New immunostimulatory agents including adjuvants
Immune assessment tools to screen responses to drugs/infections/vaccines
in different individuals/subpopulations.
Products to induce enhanced innate immune protection in the lungs,
gastrointestinal tract or systemically.